Erythropoiesis-stimulating agents for the treatment of chemotherapy-induced anemia: comparisons from real-world clinical experience.

Disclosure FRL and MT are employees of Sandoz. The other authors have no conflicts to declare. Medical writing assistance in the preparation of this paper was provided by Tony Reardon of Spirit Medical Communications Ltd and funded by Sandoz International GmbH.